Xilong Scientific Co., Ltd. (SHE:002584)
8.04
+0.04 (0.50%)
Apr 30, 2026, 12:54 PM CST
Xilong Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 7,331 | 7,803 | 7,078 | 6,176 | 5,372 | Upgrade
|
| Other Revenue | - | 13.86 | 13.73 | 7.27 | 8.12 | Upgrade
|
| Revenue | 7,331 | 7,816 | 7,092 | 6,183 | 5,380 | Upgrade
|
| Revenue Growth (YoY) | -6.21% | 10.22% | 14.69% | 14.93% | -13.83% | Upgrade
|
| Cost of Revenue | 6,809 | 7,294 | 6,632 | 5,756 | 4,856 | Upgrade
|
| Gross Profit | 521.67 | 522.88 | 459.7 | 426.78 | 523.64 | Upgrade
|
| Selling, General & Admin | 266.42 | 243.65 | 234.82 | 211.47 | 240.76 | Upgrade
|
| Research & Development | 88.31 | 109.9 | 95.7 | 90.47 | 118.97 | Upgrade
|
| Other Operating Expenses | -3.77 | -3.54 | 5.75 | 17.19 | 16.02 | Upgrade
|
| Operating Expenses | 350.96 | 361.49 | 344.61 | 331.92 | 395.75 | Upgrade
|
| Operating Income | 170.71 | 161.39 | 115.1 | 94.86 | 127.88 | Upgrade
|
| Interest Expense | - | -46.21 | -60.86 | -49.08 | -67.5 | Upgrade
|
| Interest & Investment Income | - | 5.38 | 6.7 | 92.1 | 144.18 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -3.25 | -4.38 | -9.5 | 1.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -215.25 | -28.17 | -13.96 | -29.59 | -7.76 | Upgrade
|
| EBT Excluding Unusual Items | -44.54 | 89.15 | 42.6 | 98.79 | 198.11 | Upgrade
|
| Impairment of Goodwill | - | - | -6.54 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.8 | 0.02 | - | 0 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.48 | -0.84 | 0.21 | -0.14 | -0.39 | Upgrade
|
| Asset Writedown | -13.24 | -6.32 | -0.5 | -1.47 | 0.34 | Upgrade
|
| Other Unusual Items | - | -9.72 | 7.15 | 5.57 | 11.04 | Upgrade
|
| Pretax Income | -69.06 | 72.29 | 42.92 | 102.74 | 209.1 | Upgrade
|
| Income Tax Expense | 5.33 | 9.3 | 8.33 | 15.04 | 7.98 | Upgrade
|
| Earnings From Continuing Operations | -74.39 | 62.99 | 34.59 | 87.69 | 201.12 | Upgrade
|
| Minority Interest in Earnings | -1.1 | -1.22 | -1.24 | 1.37 | -14.06 | Upgrade
|
| Net Income | -75.49 | 61.77 | 33.35 | 89.06 | 187.06 | Upgrade
|
| Net Income to Common | -75.49 | 61.77 | 33.35 | 89.06 | 187.06 | Upgrade
|
| Net Income Growth | - | 85.24% | -62.56% | -52.39% | 228.91% | Upgrade
|
| Shares Outstanding (Basic) | 581 | 562 | 556 | 594 | 534 | Upgrade
|
| Shares Outstanding (Diluted) | 581 | 562 | 556 | 594 | 534 | Upgrade
|
| Shares Change (YoY) | 3.40% | 1.04% | -6.39% | 11.09% | -6.02% | Upgrade
|
| EPS (Basic) | -0.13 | 0.11 | 0.06 | 0.15 | 0.35 | Upgrade
|
| EPS (Diluted) | -0.13 | 0.11 | 0.06 | 0.15 | 0.35 | Upgrade
|
| EPS Growth | - | 83.33% | -60.00% | -57.14% | 250.00% | Upgrade
|
| Free Cash Flow | -30.75 | 257.23 | -499.96 | -514.59 | 316.27 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | 0.46 | -0.90 | -0.87 | 0.59 | Upgrade
|
| Dividend Per Share | - | 0.033 | 0.020 | - | - | Upgrade
|
| Dividend Growth | - | 65.00% | - | - | - | Upgrade
|
| Gross Margin | 7.12% | 6.69% | 6.48% | 6.90% | 9.73% | Upgrade
|
| Operating Margin | 2.33% | 2.07% | 1.62% | 1.53% | 2.38% | Upgrade
|
| Profit Margin | -1.03% | 0.79% | 0.47% | 1.44% | 3.48% | Upgrade
|
| Free Cash Flow Margin | -0.42% | 3.29% | -7.05% | -8.32% | 5.88% | Upgrade
|
| EBITDA | 240.74 | 203.36 | 155.22 | 130.97 | 157.56 | Upgrade
|
| EBITDA Margin | 3.28% | 2.60% | 2.19% | 2.12% | 2.93% | Upgrade
|
| D&A For EBITDA | 70.03 | 41.97 | 40.13 | 36.11 | 29.68 | Upgrade
|
| EBIT | 170.71 | 161.39 | 115.1 | 94.86 | 127.88 | Upgrade
|
| EBIT Margin | 2.33% | 2.07% | 1.62% | 1.53% | 2.38% | Upgrade
|
| Effective Tax Rate | - | 12.86% | 19.41% | 14.64% | 3.82% | Upgrade
|
| Revenue as Reported | - | 7,816 | 7,092 | 6,183 | 5,380 | Upgrade
|
| Advertising Expenses | - | 3.85 | 0.39 | 3.73 | 0.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.